What investor type does IQVIA fit best in FoxScore?

IQVIA looks fairly balanced in FoxScore: the sub-scores are close to each other. This often fits a diversified approach — then check the metrics (e.g., drawdowns/volatility) to see if they match your risk tolerance.

How meaningful is the available history for IQVIA?

IQVIA currently has about 12.8 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for IQVIA

IQV · As of: 02/17/2026

Basic information

Type: Stock

Region: US

Sector: Health Care

TER: –

History

Available history:12.8 years

Last tradingday:02/17/2026

Description & usage

IQVIA is a key partner to pharma and biotech, combining clinical research services with data, analytics and software used in development and commercialization. Backlog and pipeline provide visibility, while study complexity and pricing pressure can affect margins. Outsourcing intensity, R&D budgets and the health of biotech funding markets often influence demand.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

IQVIA (IQV) currently has a total score of 30 points, placing it in the weak range. The score is made up of Performance (34), Stability (26) and Trend (26). All three sub-scores are currently below average.

Performance scores 34 points (weak). Least weak metric: 10Y return at 192.3 %. Main drag: 3Y return at -29.0 %. This suggests stronger long-term than short-term performance.

Stability scores 26 points (weak). Least weak metric: CAGR/drawdown ratio at 0.22. Main drag: Sharpe ratio (90d) at -0.83. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 26 points (weak). Trend signals are mostly negative right now. Key strength: 12M momentum at 23.1 %. Main drag: Price is about 26.3 % below SMA50.

Overall, the profile is fairly consistent across dimensions. On a metric level, 12M momentum stands out, while SMA50 distance is the main weak spot.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

weak

Scores

Metrics

FAQ

What investor type does IQVIA fit best in FoxScore?: IQVIA looks fairly balanced in FoxScore: the sub-scores are close to each other. This often fits a diversified approach — then check the metrics (e.g., drawdowns/volatility) to see if they match your risk tolerance.
How meaningful is the available history for IQVIA?: IQVIA currently has about 12.8 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.